Neutralization of tumor necrosis factor abrogates hepatic failure induced by α-galactosylceramide without attenuating its antitumor effect in aged mice

Journal of Hepatology

Volumn 43, Issue 4, 2005, Pages 670-678

  Inui, Takuo ^a   Nakashima, Hiroyuki ^a   Habu, Yoshiko ^a   Nakagawa, Ryusuke ^b   Fukasawa, Masashi ^a   Kinoshita, Manabu ^a   Shinomiya, Nariyoshi ^a   Seki, Shuhji ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^b KAGAWA UNIVERSITY   (Japan)

Author keywords

Galactosylceramide; Antitumor immunity; Fas ligand; Hepatotoxicity; NK1.1 Ag+ T cells; TNF

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA GALACTOSYLCERAMIDE; FAS LIGAND; GAMMA INTERFERON; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ANTIBODY;

AGE; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HISTOPATHOLOGY; KIDNEY TUMOR; LIVER FAILURE; LIVER TUMOR; LUNG TUMOR; LYMPHOMA CELL; MORTALITY; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR IMMUNITY;

AGING; ALANINE TRANSAMINASE; ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL SURVIVAL; CREATININE; FLOW CYTOMETRY; GALACTOSYLCERAMIDES; INTERFERON TYPE II; L-LACTATE DEHYDROGENASE; LIVER; LIVER FAILURE; LYMPHOMA; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; TUMOR NECROSIS FACTOR-ALPHA;

EID: 24344475298     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2005.02.027     Document Type: Article

References (46)

1. S. Seki, T. Abo, T. Ohteki, K. Sugiura, and K. Kumagai Unusual alpha beta-T cells expanded in autoimmune lpr mice are probably a counterpart of normal T cells in the liver J Immunol 147 1991 1214 1221
2. W. Hashimoto, K. Takeda, R. Anzai, K. Ogasawara, H. Sakihara, and K. Sugiura Cytotoxic NK1.1 Ag+ alpha beta T cells with intermediate TCR induced in the liver of mice by IL-12 J Immunol 154 1995 4333 4340
3. H.R. MacDonald NK1.1+ T cell receptor-alpha/beta+ cells: new clues to their origin, specificity, and function J Exp Med 182 1995 633 638
4. A. Tsukahara, S. Seki, T. Iiai, T. Moroda, H. Watanabe, and S. Suzuki Mouse liver T cells: their change with aging and in comparison with peripheral T cells Hepatology 26 1997 301 309
5. O. Lantz, and A. Bendelac An invariant T cell receptor alpha chain is used by a unique subset of major histocompatibility complex class I-specific CD4+ and CD4-8- T cells in mice and humans J Exp Med 180 1994 1097 1106
6. A. Bendelac Positive selection of mouse NK1+ T cells by CD1-expressing cortical thymocytes J Exp Med 182 1995 2091 2096
7. H. Arase, N. Arase, K. Nakagawa, R.A. Good, and K. Onoe NK1.1+CD4+CD8- thymocytes with specific lymphokine secretion Eur J Immunol 23 1993 307 310
8. K. Ogasawara, K. Takeda, W. Hashimoto, M. Satoh, R. Okuyama, and N. Yanai Involvement of NK1+ T cells and their IFN-gamma production in the generalized Shwartzman reaction J Immunol 160 1998 3522 3527
9. T. Kawano, J. Cui, Y. Koezuka, I. Toura, Y. Kaneko, and K. Motoki CD1d-restricted and TCR-mediated activation of V alpha14 NKT cells by glycosylceramides Science 278 1997 1626 1629
10. R. Nakagawa, I. Nagafune, Y. Tazunoki, H. Ehara, H. Tomura, and R. Iijima Mechanisms of the antimetastatic effect in the liver and of the hepatocyte injury induced by alpha-galactosylceramide in mice J Immunol 166 2001 6578 6584
11. R. Nakagawa, T. Inui, I. Nagafune, Y. Tazunoki, K. Motoki, and A. Yamauchi Essential role of bystander cytotoxic CD122+CD8+ T cells for the antitumor immunity induced in the liver of mice by alpha-galactosylceramide J Immunol 172 2004 6550 6557
12. T. Inui, R. Nakagawa, S. Ohkura, Y. Habu, Y. Koike, and K. Motoki Age-associated augmentation of the synthetic ligand-mediated function of mouse NK1.1 Ag(+) T cells: their cytokine production and hepatotoxicity in vivo and in vitro J Immunol 169 2002 6127 6132
13. R. Romero, and J.E. Lavine Cytokine inhibition of the hepatitis B virus core promoter Hepatology 23 1996 17 23
14. C. Alvarado Esquivel, A. Elewaut, J. Philippe, A.E. Elewaut, I. Desombere, and G. Maertens Evolution of hepatitis C virus-specific T cell responses and cytokine production in chronic hepatitis C patients treated with high doses of interferon-alpha Rev Invest Clin 54 2002 41 50
15. G. Tiegs, M. Wolter, and A. Wendel Tumor necrosis factor is a terminal mediator in galactosamine/endotoxin-induced hepatitis in mice Biochem Pharmacol 38 1989 627 631
16. P.N. Gilles, D.L. Guerrette, R.J. Ulevitch, R.D. Schreiber, and F.V. Chisari HBsAg retention sensitizes the hepatocyte to injury by physiological concentrations of interferon-gamma Hepatology 16 1992 655 663
17. Y. Nakamoto, L.G. Guidotti, V. Pasquetto, R.D. Schreiber, and F.V. Chisari Differential target cell sensitivity to CTL-activated death pathways in hepatitis B virus transgenic mice J Immunol 158 1997 5692 5697
18. H. Tsutsui, K. Matsui, N. Kawada, Y. Hyodo, N. Hayashi, and H. Okamura IL-18 accounts for both TNF-alpha- and Fas ligand-mediated hepatotoxic pathways in endotoxin-induced liver injury in mice J Immunol 159 1997 3961 3967
19. A.M. Diehl Cytokine regulation of liver injury and repair Immunol Rev 174 2000 160 171
20. J. Ogasawara, R. Watanabe-Fukunaga, M. Adachi, A. Matsuzawa, T. Kasugai, and Y. Kitamura Lethal effect of the anti-Fas antibody in mice Nature 364 1993 806 809
21. R. Ksontini, D.B. Colagiovanni, M.D. Josephs, C.K. Edwards IIIrd, C.L. Tannahill, and C.C. Solorzano Disparate roles for TNF-alpha and Fas ligand in concanavalin A-induced hepatitis J Immunol 160 1998 4082 4089
22. K. Takeda, Y. Hayakawa, L. Van Kaer, H. Matsuda, H. Yagita, and K. Okumura Critical contribution of liver natural killer T cells to a murine model of hepatitis Proc Natl Acad Sci USA 97 2000 5498 5503
23. T. Kondo, T. Suda, H. Fukuyama, M. Adachi, and S. Nagata Essential roles of the Fas ligand in the development of hepatitis Nat Med 3 1997 409 413
24. G. Tiegs, J. Hentschel, and A. Wendel A T cell-dependent experimental liver injury in mice inducible by concanavalin A J Clin Invest 90 1992 196 203
25. S. Toyabe, S. Seki, T. Iiai, K. Takeda, K. Shirai, and H. Watanabe Requirement of IL-4 and liver NK1+ T cells for concanavalin A-induced hepatic injury in mice J Immunol 159 1997 1537 1542
26. Y. Kaneko, M. Harada, T. Kawano, M. Yamashita, Y. Shibata, and F. Gejyo Augmentation of Valpha14 NKT cell-mediated cytotoxicity by interleukin 4 in an autocrine mechanism resulting in the development of concanavalin A-induced hepatitis J Exp Med 191 2000 105 114
27. M. Morita, K. Motoki, K. Akimoto, T. Natori, T. Sakai, and E. Sawa Structure-activity relationship of alpha-galactosylceramides against B16-bearing mice J Med Chem 38 1995 2176 2187
28. K. Motoki, K. Maeda, H. Ueno, E. Kobayashi, T. Uchida, and H. Fukushima Antitumor activities of combined treatment with a novel immunomodulator, (2S,3S,4R)-1-O-(alpha-D-Galactopyranosyl)-2-(N-Hexacosanoylamino)-1,3, 4-octadecanetriol (KRN7000), and radiotherapy in tumor-bearing mice Oncol Res 8 1996 155 162
29. T. Inui, N. Shinomiya, M. Fukasawa, M. Kobayashi, N. Kuranaga, and S. Ohkura Growth-related signaling regulates activation of telomerase in regenerating hepatocytes Exp Cell Res 273 2002 147 156
30. U. Walter, A. Frantzke, A. Sarukhan, C. Zober, H. von Boehmer, and J. Buer Monitoring gene expression of TNFR family members by beta-cells during development of autoimmune diabetes Eur J Immunol 30 2000 1224 1232
31. R. Nakagawa, K. Motoki, H. Nakamura, H. Ueno, R. Iijima, and A. Yamauchi Antitumor activity of alpha-galactosylceramide, KRN7000, in mice with EL-4 hepatic metastasis and its cytokine production Oncol Res 10 1998 561 568
32. S.F. Schlosser, F. Azzaroli, T. Dao, R. Hingorani, I. Nicholas Crispe, and J.L. Boyer Induction of murine hepatocyte death by membrane-bound CD95 (Fas/APO-1)-ligand: characterization of an in vitro system Hepatology 32 2000 779 785
33. K. Takeda, S. Seki, K. Ogasawara, R. Anzai, W. Hashimoto, and K. Sugiura Liver NK1.1+CD4+alpha beta T cells activated by IL-12 as a major effector in inhibition of experimental tumor metastasis J Immunol 156 1996 3366 3373
34. H. Arase, N. Arase, Y. Kobayashi, Y. Nishimura, S. Yonehara, and K. Onoe Cytotoxicity of fresh NK1.1+T cell receptor alpha/beta+ thymocytes against a CD4+8+thymocyte population associated with intact Fas antigen expression on the target J Exp Med 180 1994 423 432
35. T. Moroda, T. Iiai, S. Suzuki, A. Tsukahara, T. Tada, and M. Nose Autologous killing by a population of intermediate T-cell receptor cells and its NK1.1+ and NK1.1- subsets, using Fas ligand/Fas molecules Immunology 91 1997 219 226
36. T. Ohteki, S. Seki, T. Abo, and K. Kumagai Liver is a possible site for the proliferation of abnormal CD3+4-8-double-negative lymphocytes in autoimmune MRL-lpr/lpr mice J Exp Med 172 1990 7 12
37. T. Masuda, T. Ohteki, T. Abo, S. Seki, S. Nose, and H. Nagura Expansion of the population of double negative CD4-8-T alpha beta-cells in the liver is a common feature of autoimmune mice J Immunol 147 1991 2907 2912
38. G. Zajicek, R. Oren, and M. Weinreb Jr The streaming liver Liver 5 1985 293 300
39. J. Desbarats, and M.K. Newell Fas engagement accelerates liver regeneration after partial hepatectomy Nat Med 6 2000 920 923
40. Y. Habu, T. Uchida, T. Inui, H. Nakashima, M. Fukasawa, and S. Seki Enhancement of the synthetic ligand-mediated function of liver NK1.1Ag+ T cells in mice by interleukin-12 pretreatment Immunology 113 2004 35 43
41. Y. Osman, T. Kawamura, T. Naito, K. Takeda, L. Van Kaer, and K. Okumura Activation of hepatic NKT cells and subsequent liver injury following administration of alpha-galactosylceramide Eur J Immunol 30 2000 1919 1928
42. A. Hameg, I. Apostolou, M. Leite-De-Moraes, J.M. Gombert, C. Garcia, and Y. Koezuka A subset of NKT cells that lacks the NK1.1 marker, expresses CD1d molecules, and autopresents the alpha-galactosylceramide antigen J Immunol 165 2000 4917 4926
43. M.T. Wilson, C. Johansson, D. Olivares-Villagomez, A.K. Singh, A.K. Stanic, and C.R. Wang The response of natural killer T cells to glycolipid antigens is characterized by surface receptor down-modulation and expansion Proc Natl Acad Sci USA 100 2003 10913 10918
44. N.Y. Crowe, A.P. Uldrich, K. Kyparissoudis, K.J. Hammond, Y. Hayakawa, and S. Sidobre Glycolipid antigen drives rapid expansion and sustained cytokine production by NK T cells J Immunol 171 2003 4020 4027
45. M. Feldmann Development of anti-TNF therapy for rheumatoid arthritis Nat Rev Immunol 2 2002 364 371
46. D.H. Present, P. Rutgeerts, S. Targan, S.B. Hanauer, L. Mayer, and R.A. van Hogezand Infliximab for the treatment of fistulas in patients with Crohn's disease N Engl J Med 340 1999 1398 1405